Schröder FH - Search Results

1

Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.

Schröder FH, Tombal B, Miller K, Boccon-Gibod L, Shore ND, Crawford ED, Moul J, Olesen TK, Persson BE. Schröder FH, et al. BJU Int. 2010 Jul;106(2):182-7. doi: 10.1111/j.1464-410X.2009.08981.x. Epub 2009 Nov 13. BJU Int. 2010. PMID: 19912212 Clinical Trial.

2

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.

de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH; European Randomized Screening for Prostate Cancer (ERSPC) Trial; International Prostate Cancer Screening Trials Evaluation Group. de Koning HJ, et al. Among authors: schroder fh. Int J Cancer. 2002 Jan 10;97(2):237-44. doi: 10.1002/ijc.1588. Int J Cancer. 2002. PMID: 11774270 Clinical Trial.

3

Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Otto SJ, van der Cruijsen IW, Liem MK, Korfage IJ, Lous JJ, Schröder FH, de Koning HJ. Otto SJ, et al. Among authors: schroder fh. Int J Cancer. 2003 Jun 20;105(3):394-9. doi: 10.1002/ijc.11074. Int J Cancer. 2003. PMID: 12704675 Clinical Trial.

4

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, de Koning HJ. Draisma G, et al. Among authors: schroder fh. J Natl Cancer Inst. 2003 Jun 18;95(12):868-78. doi: 10.1093/jnci/95.12.868. J Natl Cancer Inst. 2003. PMID: 12813170 Free article. Clinical Trial.

5

Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

Raaijmakers R, Wildhagen MF, Ito K, Pàez A, de Vries SH, Roobol MJ, Schröder FH. Raaijmakers R, et al. Among authors: schroder fh. Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028. Urology. 2004. PMID: 14972481

6

Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years.

Postma R, Roobol M, Schröder FH, van der Kwast TH. Postma R, et al. Among authors: schroder fh. Cancer. 2004 Mar 1;100(5):968-75. doi: 10.1002/cncr.20048. Cancer. 2004. PMID: 14983492 Free article. Clinical Trial.

7

Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study.

Schröder FH, Kurth KH, Fosså SD, Hoekstra W, Karthaus PP, Debois M, Collette L; Members of the European Organisation for the Research and Treatment of Cancer Genito-urinary Group. Schröder FH, et al. J Urol. 2004 Sep;172(3):923-7. doi: 10.1097/01.ju.0000135742.13171.d2. J Urol. 2004. PMID: 15310999 Clinical Trial.

8

Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study.

Kranse R, Dagnelie PC, van Kemenade MC, de Jong FH, Blom JH, Tijburg LB, Weststrate JA, Schröder FH. Kranse R, et al. Among authors: schroder fh. Int J Cancer. 2005 Feb 20;113(5):835-40. doi: 10.1002/ijc.20653. Int J Cancer. 2005. PMID: 15499622 Clinical Trial.

9

Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years.

Postma R, de Vries SH, Roobol MJ, Wildhagen MF, Schröder FH, van der Kwast TH. Postma R, et al. Among authors: schroder fh. Cancer. 2005 Feb 15;103(4):708-16. doi: 10.1002/cncr.20840. Cancer. 2005. PMID: 15648082 Free article.

10

Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?

Gosselaar C, Roobol MJ, Schröder FH. Gosselaar C, et al. Among authors: schroder fh. BJU Int. 2005 Feb;95(2):231-7. doi: 10.1111/j.1464-410X.2005.05324.x. BJU Int. 2005. PMID: 15667646 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters